Medical Marijuana: A Critical Look at Medicine, Politics, Public Health, and Profits



Although medical marijuana is legal in forty-two states, widespread confusion exists about what cannabinoids can and can’t do, as most medical professionals do not receive formal education about marijuana. Attendees receive updated information about the therapeutic benefits, risks, and limits of cannabis and cannabinoid products, as well as the political and economic factors that influence the medical marijuana market.


  • Discuss the current science behind the therapeutic value of cannabinoids.
  • Discuss the current science related to risks of cannabinoid use, particularly at high concentrations.
  • Explain the experience of medical marijuana patients in dispensaries, related to recommendations and product marketing.
  • Explain the impact of the marijuana industry on state and federal policy change, and implications related to recreational use and commercial markets.
Target Audience: Psychologists, Social Workers, Addiction Counselors, LMFT, & Licensed Professional Counselors
Content level: Beginner to intermediate
2 CE hour credits approved by
ASWB # 1706, NAADAC # 139138 & NBCC # 6703
State Board Approval
ADACBGA # 19-12-17-1212
FCB # 5387-A
OCDP Board Sponsor # 50-29024
CE Broker Tracking # 50-29024

Course Features

  • Lectures 2
  • Quizzes 0
  • Duration 2 hours
  • Skill level All levels
  • Language English
  • Students 27
  • Certificate Yes
  • Assessments Yes
    • Lecture.1
      Medical Marijuana: A Critical Look at Medicine, Politics, Public Health, and Profits

Aaron Weiner, PhD, ABPP is a board-certified Psychologist and addiction specialist, and speaks nationally on the topics of addiction, behavioral health, and the impact of drug policy on public health. He earned his doctorate from the University of Illinois at Urbana-Champaign and completed his fellowship in Addiction Psychology at the VA Ann Arbor Healthcare System. His perspective is informed by his years of experience growing and directing addiction service lines for healthcare systems, the current state of medical and psychological research, and his own observations in private practice. He is a strong advocate for evidence-based care in treating chemical dependency and behavioral addictions, as well as a proponent of integrating behavioral health services into medical settings. Dr. Weiner is a member of the Physician Speakers Bureau for the National Safety Council, the Science Advisory Board for Smart Approaches to Marijuana, and a former Board Member for the Society of Addiction Psychology.


Thursday, April 29, 2021, from 4:00-6:00 PM EST.

Please check your time zone below:
3:00-5:00 PM Central Standard Time
2:00-4:00 PM Mountain Standard Time
1:00-4:00 PM Pacific Standard Time
12:00 PM-2:00 PM Alaska
11:30 AM-1:00 PM Hawaii